Multimeric Disintegrin Protein Polymer Fusions That Target Tumor Vasculature

[Image: see text] Recombinant protein therapeutics have increased in number and frequency since the introduction of human insulin, 25 years ago. Presently, proteins and peptides are commonly used in the clinic. However, the incorporation of peptides into clinically approved nanomedicines has been li...

Descripción completa

Detalles Bibliográficos
Autores principales: Janib, Siti M., Gustafson, Joshua A., Minea, Radu O., Swenson, Stephen D., Liu, Shuanglong, Pastuszka, Martha K., Lock, Lye Lin, Cui, Honggang, Markland, Francis S., Conti, Peter S., Li, Zibo, MacKay, J. Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098058/
https://www.ncbi.nlm.nih.gov/pubmed/24871936
http://dx.doi.org/10.1021/bm401622y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098058/
https://www.ncbi.nlm.nih.gov/pubmed/24871936
http://dx.doi.org/10.1021/bm401622y

Ejemplares similares